Home » Topics » BioWorld Science, Conferences

BioWorld Science, Conferences
RSS

In vivo evaluation of the novel nAChR agonist PF-4888086 in models of antipsychotic activity

Oct. 27, 2009

Phase I trial of recombinant human acid sphingomyelinase in type B Niemann-Pick disease reported

Oct. 27, 2009

Canakinumab trials show efficacy in juvenile idiopathic arthritis and gouty arthritis

Oct. 27, 2009

Recombinant adenovirus serotype 26 HIV-1 vaccine safe, immunogenic in humans

Oct. 27, 2009

Naproxcinod efficacy similar to naproxen in knee osteoarthritis patients

Oct. 26, 2009

IMO-3100 active in arthritis model, intended for clinical development

Oct. 26, 2009

KB-099520 increases serotonergic activity and demonstrates antidepressant effects

Oct. 26, 2009

Preclinical characterization of SEP-230864 presented by Sepracor

Oct. 26, 2009

PSN-0041 displays enhanced antidepressant activity over native amylin in preclinical tests

Oct. 26, 2009

Phase I study results encourage further development of anesthetic PF-0713

Oct. 26, 2009

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 1, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 30, 2026
CINP 2026: Gut microbiota could predict antidepressant response
BioWorld
The gut microbiota may be altered in people with depression as a result of treatment. These microorganisms reorganize differently in individuals who respond to...
Ascending BCI systems deepen national security, ethical concerns
BioWorld
Ready or not, the future has arrived. Novel AI and brain-computer interface (BCI) systems are no longer confined to the realm of science fiction. As an...
Deep brain stimulation from the shallows: tomorrow’s BCI technology?
BioWorld
Deep brain stimulation (DBS) through implanted electrodes has enabled fundamentally new ways of treating certain disorders. More than 100,000 severely ill...